{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:17:54Z","timestamp":1791339474834,"version":"4.3.1"},"reference-count":21,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-028691"],"award-info":[{"award-number":["INV-028691"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["COVID-19 CTA GPP"],"award-info":[{"award-number":["COVID-19 CTA GPP"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"award":["INV-028691"],"award-info":[{"award-number":["INV-028691"]}],"id":[{"id":"https:\/\/ror.org\/0456r8d26","id-type":"ROR","asserted-by":"publisher"}]},{"award":["COVID-19 CTA GPP"],"award-info":[{"award-number":["COVID-19 CTA GPP"]}],"id":[{"id":"https:\/\/ror.org\/0456r8d26","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI171443"],"award-info":[{"award-number":["U19AI171443"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"award":["U19AI171443"],"award-info":[{"award-number":["U19AI171443"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The use of covalent warheads targeting the catalytic cysteine has been a cornerstone in the coronavirus main protease (Mpro) inhibitor development. Various electrophilic motifs have been explored, including aldehydes, nitriles, ketoamides, and hydroxymethyl ketones (HMKs). Recent efforts have mostly centered around nitrile warheads, given the success of Nirmatrelvir in the clinic. However, it is essential to identify and develop alternative chemotypes with distinct chemical and pharmacological profiles to prepare for future pandemics. Among such alternatives, HMKs are of particular interest because they balance reduced intrinsic electrophilicity with an excellent selectivity profile. Nevertheless, early HMK-based compounds, such as the clinical-stage Mpro inhibitor PF-00835231, suffered from poor oral bioavailability and therefore required intravenous administration, with or without prodrug derivatization of the hydroxyl group. In this work, we describe our efforts to advance the HMK field by discovering mCMX110, a lead compound that exhibits superior potency, increased unbound exposure in vivo, and favorable oral bioavailability in preclinical studies.<\/jats:p>","DOI":"10.3390\/v18080821","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:11:56Z","timestamp":1785168716000},"page":"821","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-1477","authenticated-orcid":false,"given":"N. G. R. Dayan","family":"Elshan","sequence":"first","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3100-7462","authenticated-orcid":false,"given":"Frank O.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Ghorai","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-9532","authenticated-orcid":false,"given":"Gennadii","family":"Grabovyi","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Wilson","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2414-7341","authenticated-orcid":false,"given":"Laura","family":"Riva","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley K.","family":"Woods","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Pedroarena","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Nazarian","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyin","family":"Liu","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wrickban","family":"Mazumdar","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirui","family":"Song","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8471-183X","authenticated-orcid":false,"given":"Neechi","family":"Okwor","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Malvin","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3337-6528","authenticated-orcid":false,"given":"Malina A.","family":"Bakowski","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4335-5342","authenticated-orcid":false,"given":"Melanie G.","family":"Kirkpatrick","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2271-3116","authenticated-orcid":false,"given":"Amal","family":"Gebara-Lamb","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8933-1321","authenticated-orcid":false,"given":"Edward","family":"Huang","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2n T. B.","family":"Nguyen-Tran","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Weston","sequence":"additional","affiliation":[{"name":"Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-5952","authenticated-orcid":false,"given":"Carly","family":"Dillen","sequence":"additional","affiliation":[{"name":"Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Chi","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangwei","family":"Li","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-0775","authenticated-orcid":false,"given":"Matthew B.","family":"Frieman","sequence":"additional","affiliation":[{"name":"Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit K.","family":"Chanda","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5754-3407","authenticated-orcid":false,"given":"Case W.","family":"McNamara","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-9597","authenticated-orcid":false,"given":"Anil Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rahimi","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-8117","authenticated-orcid":false,"given":"Jian Jeffrey","family":"Chen","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean B.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"},{"name":"Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab K.","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Calibr-Skaggs Institute for Innovative Medicines, The Scripps Research Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","article-title":"Updated Evidence for COVID-19, RSV, and Influenza Vaccines for 2025\u20132026","volume":"393","author":"Scott","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhao, H., Meng, W., Lv, X., Si, S., Wu, S., Li, J., Cai, Z., Jin, R., Yang, L., and Li, C. (2026). Nirmatrelvir\/ritonavir reduced mortality in severe or critical COVID-19 patients: A multicenter retrospective cohort study. Front. Med., 13.","DOI":"10.3389\/fmed.2026.1747565"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e70157","DOI":"10.1002\/rmv.70157","article-title":"SARS-CoV-2 Variants and Immune Evasion: Mapping the Future of Vaccine Design","volume":"36","author":"Uzer","year":"2026","journal-title":"Rev. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2460045","DOI":"10.1080\/14756366.2025.2460045","article-title":"Exploring covalent inhibitors of SARS-CoV-2 main protease: From peptidomimetics to novel scaffolds","volume":"40","author":"Atatreh","year":"2025","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e0056224","DOI":"10.1128\/aac.00562-24","article-title":"Design of novel and highly selective SARS-CoV-2 main protease inhibitors","volume":"68","author":"Poli","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10953","DOI":"10.1021\/acs.jmedchem.4c03147","article-title":"Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 M(pro) and Cathepsin","volume":"68","author":"Porzberg","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/cr010182v","article-title":"Irreversible inhibitors of serine, cysteine, and threonine proteases","volume":"102","author":"Powers","year":"2002","journal-title":"Chem. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","article-title":"Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19","volume":"63","author":"Hoffman","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","article-title":"Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19","volume":"12","author":"Boras","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1021\/acs.jmedchem.3c01938","article-title":"Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead","volume":"67","author":"Elshan","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.omtn.2023.03.013","article-title":"Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?","volume":"32","author":"Chatterjee","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Costacurta, F., Dodaro, A., Bante, D., Schoppe, H., Peng, J.Y., Sprenger, B., He, X., Moghadasi, S.A., Egger, L.M., and Fleischmann, J. (2024). A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012522"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eadl4013","DOI":"10.1126\/sciadv.adl4013","article-title":"In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2552716","DOI":"10.1080\/22221751.2025.2552716","article-title":"SARS-CoV-2 Mpro inhibitor ensitrelvir: Asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots","volume":"14","author":"Zhou","year":"2025","journal-title":"Emerg. Microbes Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1093\/infdis\/jiaf294","article-title":"Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance","volume":"232","author":"Deschenes","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/s41467-021-23328-0","article-title":"Drug repurposing screens identify chemical entities for the development of COVID-19 interventions","volume":"12","author":"Bakowski","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cber.19350680142","article-title":"Ein Verfahren zur \u00dcberf\u00fchrung von Carbons\u00e4uren in ihre h\u00f6heren Homologen bzw. deren Derivate","volume":"68","author":"Arndt","year":"2006","journal-title":"Berichte Dtsch. Chem. Ges. (A B Ser.)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1021\/acsmedchemlett.4c00146","article-title":"SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme","volume":"15","author":"Blankenship","year":"2024","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/821\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:13:03Z","timestamp":1785168783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/8\/821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["v18080821"],"URL":"https:\/\/doi.org\/10.3390\/v18080821","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]}}}